http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#Head
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#assertion
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#provenance
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#pubinfo
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#assertion
http://purl.obolibrary.org/obo/DOID_7148
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_7148
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01281
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
http://www.w3.org/2000/01/rdf-schema#label
orencia is a selective t cell costimulation modulator indicated for adult rheumatoid arthritis ra 1 1 1 1 juvenile idiopathic arthritis 1 2 1 2 adult psoriatic arthritis psa 1 3 1 3 important limitations of use 1 4 1 4 5 1 orencia r orencia is indicated for reducing signs and symptoms in patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis orencia may be used as monotherapy or concomitantly with methotrexate mtx orencia is indicated for the treatment of adult patients with active psoriatic arthritis psa orencia should not be administered concomitantly with tnf antagonists orencia is not recommended for use concomitantly with other biologic rheumatoid arthritis ra therapy such as anakinra
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01281
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#provenance
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#pubinfo
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig
http://purl.org/nanopub/x/hasSignature
FbZUsRIWQk13ON0qa92JaJ7E2ZQGYsOxQ4F/Q9v+oRTGm3qiJXFfsiXRhs/7XNrwxWrdLMgPposqi1BtX8CE7IqhWTHR69HbkBdmZzZgYWC4xQ9lCM2GDCIqkXFqgHJhQnwnnzMezkBUokK4zH3RGT+LfQkRjy80LRqs+5K9it0=
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://purl.org/dc/terms/created
2021-06-12T12:38:34.922+02:00
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs